1. Chima SC, Agostini HT, Ryschkewitsch CF, Lucas SB, Stoner GL (1999) Progressive multifocal leukoencephalopathy and JC virus genotypes in West African patients with acquired immunodeficiency syndrome: a pathologic and DNA sequence analysis of 4 cases. Arch Pathol Lab Med 123(5):395–403
2. Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M (2010) Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 68(3):295–303
3. Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, Hoen AG, Christensen BC, Kelsey KT, Marsit CJ, Pawlita M, Karagas MR (2016) Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol 183(1):61–69
4. Jensen PN, Major EO (2001) A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neuro-Oncol 7(4):280–287
5. Kumwenda JJ, Mateyu G, Kampondeni S, van Dam AP, van Lieshout L, Zijlstra EE (2005) Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke 36(5):960–964